Clinical Trials Logo
  1. Home
  2. Other
  3. NCT03343444

Safety & Efficacy of Sofosbuvir 400mg/Ledipasvir 90mg in the Treatment of Chronic Hepatitis C Adolescents

Hepatitis C Virus Infection, Response to Therapy of Clinical Trial

Official title:
Safety & Efficacy of Sofosbuvir 400mg/Ledipasvir 90mg in the Treatment of Chronic Hepatitis C Adolescents

Clinical Trial Summary

Randomized, open-label study in treatment naïve and treatment experienced, adolescence to determine the efficacy of Sofosbuvir 400mg/ledipasvir 90mg in treatment naïve and treatment-experienced adolescence. Hepatitis C virus (HCV) infection as measured by the proportion of subjects with sustained viral response 12 weeks after discontinuation of therapy (SVR12)

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03343444
Study type Interventional
Source Egyptian Liver Hospital
Contact
Status Enrolling by invitation
Phase Phase 3
Start date April 15, 2017
Completion date May 31, 2019
View Details
See also
  Status Clinical Trial Phase
Completed NCT04596475 - Prevention of Transmission of Hepatitis C Virus (HCV) From HCV-Viremic Organ Donor Phase 1/Phase 2
Recruiting NCT05361603 - Acceptability of Simultaneous Screening for Viral Hepatitis B, C and HIV Among Drug Users in Non-conventional Structures
Recruiting NCT05376943 - Possible Differences in HCC Course Depending on DAA Treatment
Recruiting NCT04251572 - HCV Reinfection After DAA Therapy in PWID in Belgium N/A
Completed NCT03369327 - Sofosbuvir and Daclatasvir for Treating Hepatitis C in 200 Patients Co-infected With Human Immunodeficiency Virus Phase 3
Recruiting NCT04768517 - HCV Reinfection in in HIV/HCV-coinfected Patients Achieving SVR by Antiviral Therapy
Recruiting NCT04732832 - HCV Reinfection in HD Patients Achieving SVR
Recruiting NCT01572233 - Effects of Activity and Education Program on Patients With Chronic Hepatitis C Infection N/A
Withdrawn NCT03381859 - Clinical Trial to eLiminate HCV-infection in Treatment-naïve, Renally Impaired EgyptiAn Patients on Renal Dialysis, With Chronic Hepatitis C Genotype 4 Phase 4
Recruiting NCT04677153 - Rapid HCV Treatment Access for Persons Who Use Drugs N/A
Completed NCT03453346 - Safety and Efficacy of Generic Sofosbuvir and Ribavirin for Treatment-naive Genotype 2 Chronic Hepatitis C N/A
Completed NCT02402218 - CHAMPS Study: Chronic HepAtitis C Management to ImProve OutcomeS N/A
Completed NCT01473056 - Study to Assess Safety,Tolerability,Pharmacokinetics & Antiviral Activity of JTK-853 in Hepatitis C Virus Genotype 1 Infected Subjects Phase 1
Completed NCT03250910 - Generic VEL/SOF With or Without RBV for HIV/HCV Coinfected Patients Phase 4